Andrew X. Chen
发表
S. Mukherjee,
R. Rabadán,
Lorin Crawford,
2016
.
R. Rabadán,
Andrew X. Chen,
P. Canoll,
2019,
Nature Medicine.
Andrew X. Chen,
R. Rabad'an,
2017,
1705.06823.
Xinzheng V. Guo,
R. Rabadán,
Andrew X. Chen,
2022,
Oncoimmunology.
R. Rabadán,
Andrew X. Chen,
D. Farber,
2019,
Cell reports.
Shing M. Lee,
R. Rabadán,
Andrew X. Chen,
2021
.
Shing M. Lee,
R. Rabadán,
Andrew X. Chen,
2021,
Clinical Cancer Research.
Sayan Mukherjee,
Lorin Crawford,
Anthea Monod,
2016,
Journal of the American Statistical Association.
Sayan Mukherjee,
Lorin Crawford,
Andrew X. Chen,
2016
.
R. Rabadán,
Andrew X. Chen,
F. Al-Shahrour,
2020,
Nature medicine.
Andrew X. Chen,
F. Al-Shahrour,
M. Soengas,
2020,
Nature Medicine.
In-Hee Lee,
Raul Rabadan,
Chul-Kee Park,
2017,
Nature Genetics.
Daniel I. S. Rosenbloom,
A. Iavarone,
Pablo G. Cámara,
2017,
Nature Genetics.
R. Rabadán,
Andrew X. Chen,
P. Canoll,
2019,
Nature Medicine.
A. Iavarone,
R. Rabadán,
Andrew X. Chen,
2021,
Genome Medicine.
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
D. Brat,
R. Stupp,
R. Rabadán,
2021,
Nature Cancer.
R. Rabadán,
Anthea Monod,
Andrew X. Chen,
2020,
Cancer research.
Raúl Rabadán,
Andrew X. Chen,
R. Rabadán,
2015,
BIRS-IMLKE.
R. Rabadán,
Andrew X. Chen,
P. Canoll,
2019,
Nature Medicine.
Daniel I. S. Rosenbloom,
A. Blumberg,
A. Iavarone,
2017,
Nature Genetics.